Latest Capital Raises News

Tasmea Limited has completed a fully underwritten A$43 million institutional placement, aiming to accelerate acquisitions, reduce debt, and enhance its chances of joining the ASX 300 Index.

Wagners Holding Company Limited has launched a A$30 million institutional placement to reduce debt and accelerate growth in its core Construction Materials and Composite Fibre Technologies businesses following a robust FY25 performance.

Wagners Holding Company Limited has secured $30 million through a strongly supported placement to fund growth in its construction materials and composite fibre technologies divisions.

Kuniko Limited updates its prospectus to extend its entitlement offer, enter a joint venture for the Commonwealth Project, and secure partial underwriting from GBA Capital.

Austral Resources Australia Ltd is advancing its strategy to become a mid-tier copper producer by consolidating key assets in Queensland’s Mount Isa copper belt, supported by a $40 million capital raise.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

PolarX Limited's trading suspension has been lifted immediately following its announcement of a new capital raising, signaling renewed market activity for the mining explorer.

PolarX has raised $5 million through a share placement to ramp up exploration at its Humboldt Range Gold Project in Nevada, complementing a major joint venture with Northern Star Resources in Alaska.

EMU NL has announced a non-renounceable entitlement offer to raise approximately $1.83 million to fund exploration at its Georgetown and Badja projects, while facing significant governance challenges ahead of a pivotal shareholder meeting.

M3 Mining Limited has raised $2.25 million through a share placement to fund exploration at its Victorian projects and pursue strategic acquisitions, signaling a renewed focus under new leadership.

Rewardle Holdings has cleared a major compliance hurdle by releasing its preliminary report, spotlighting its strategic investment in cardiac MedTech firm CloudHolter and ongoing B2B2C platform development.

Rewardle Holdings reported a modest revenue increase for FY25 but saw its loss more than double, driven by investments in AI-powered MedTech associate CloudHolter and expanded platform initiatives.